Phospho-tau217 (p-tau217) antibody and antigen (Recombinant protein)
Diagnostic Phospho-tau217 (p-tau217) antibodies (anti-Phospho-tau217, anti-p-tau217) and antigens (recombinant Phospho-tau217 (p-tau217) protein) for Neurodegenerative diseases p-tau217 detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-h-p-tau217-Ag01 | Anti-human MAPT/p-tau217/MAPTL/MTBT1 mouse monoclonal antibody (mAb) | 3090 |
GMP-h-p-tau217-Ag02 | Recombinant human MAPT/p-tau217/MAPTL/MTBT1 Protein | 28000 |
GMP-h-p-tau217-Ab01 | Anti-human MAPT/p-tau217/MAPTL/MTBT1 mouse monoclonal antibody (mAb) | 1953 |
GMP-h-p-tau217-Ab02 | Anti-human MAPT/p-tau217/MAPTL/MTBT1 mouse monoclonal antibody (mAb) | 1953 |
GMP-h-p-tau217-Ab03 | Anti-human MAPT/p-tau217/MAPTL/MTBT1 human monoclonal antibody (mAb) | 1953 |
GMP-h-p-tau217-Ab04 | Anti-human MAPT/p-tau217/MAPTL/MTBT1 human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-h-p-tau217-Ag01, GMP-h-p-tau217-Ab01, GMP-h-p-tau217-Ab02 |
Product Name | Anti-human MAPT/p-tau217/MAPTL/MTBT1 mouse monoclonal antibody (mAb) |
Target/Biomarker | Phospho-tau217 (p-tau217) |
Alias of Target/Biomarker | DDPAC, FTDP-17, MAPTL, MSTD, MTBT1, MTBT2, PPND, PPP1R103, TAU, Tau-PHF6, tau-40 |
Expression platform | synthesized |
Isotypes | NA |
Bioactivity validation | Phospho-tau217 (p-tau217) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in p-tau217 level test of Neurodegenerative diseases (Alzheimer Disease (AD)) and related syndrome evaluation. |
Products description | Anti-human MAPT/p-tau217/MAPTL/MTBT1 mouse monoclonal antibody (mAb) was expressed in synthesized expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-h-p-tau217-Ag02 |
Product Name | Recombinant human MAPT/p-tau217/MAPTL/MTBT1 Protein |
Target/Biomarker | Phospho-tau217 (p-tau217) |
Alias of Target/Biomarker | DDPAC, FTDP-17, MAPTL, MSTD, MTBT1, MTBT2, PPND, PPP1R103, TAU, Tau-PHF6, tau-40 |
Expression platform | mammalian |
Isotypes | Recombinant Antigen |
Bioactivity validation | Phospho-tau217 (p-tau217) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in p-tau217 level test of Neurodegenerative diseases (Alzheimer Disease (AD)) and related syndrome evaluation. |
Products description | Recombinant human MAPT/p-tau217/MAPTL/MTBT1 Protein was expressed in mammalian expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-h-p-tau217-Ab03, GMP-h-p-tau217-Ab04 |
Product Name | Anti-human MAPT/p-tau217/MAPTL/MTBT1 human monoclonal antibody (mAb) |
Target/Biomarker | Phospho-tau217 (p-tau217) |
Alias of Target/Biomarker | DDPAC, FTDP-17, MAPTL, MSTD, MTBT1, MTBT2, PPND, PPP1R103, TAU, Tau-PHF6, tau-40 |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | Phospho-tau217 (p-tau217) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in p-tau217 level test of Neurodegenerative diseases (Alzheimer Disease (AD)) and related syndrome evaluation. |
Tag | hFc |
Products description | Anti-human MAPT/p-tau217/MAPTL/MTBT1 human monoclonal antibody (mAb) was expressed in CHO expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Figure 1. Validation of GeneMedi's Anti-human p-tau181/p-tau217/p-tau231 antibody
A. GeneMedi's GMP-h-p-tau181-Ab01 (Anti-human p-tau181 antibody) is validated to detect the GMP-h-p-tau181-Ag01 (p-tau181 antigen) in ELISA, EC50 = 25.26ng/ml.
B. GeneMedi's GMP-h-p-tau217-Ab01 (Anti-human p-tau217 antibody) is validated to detect the GMP-h-p-tau217-Ag01 (p-tau217 antigen) in ELISA, EC50 = 25.85ng/ml.
C. GeneMedi's GMP-h-p-tau231-Ab01 (Anti-human p-tau231 antibody) is validated to detect the GMP-h-p-tau231-Ag01 (p-tau231 antigen) in ELISA. EC50 = 64.34ng/ml.
Click to get more Data / Case study about the product.
Associated products
- Recommend Pair Antibody and Antigen
- Associated products
Pair Antibody and Antigen | Products detail | Cat.No | Product Name |
P-tau217 | 1. Antigen | 1. GMP-h-p-tau217-Ag01 | Phospho-tau217 (p-tau217) antigen |
2. Capture antibody | 2. GMP-h-p-tau217-Ab01 | Anti-human p-tau217 mouse monoclonal antibody(mAb) | |
3. Detector antibody | 3. GMP-h-Tau-Ab03 | Recombinant human Tau Protein | |
P-tau181 | 1. Antigen | 1. GMP-h-p-tau181-Ag01 | Phospho-tau181 (p-tau181) antigen |
2. Capture antibody | 2. GMP-h-p-tau181-Ab01 | Anti-human p-tau181 mouse monoclonal antibody(mAb) | |
3. Detector antibody | 3. GMP-h-Tau-Ab03 | Recombinant human Tau Protein | |
P-tau231 | 1. Antigen | 1. GMP-h-p-tau231-Ag01 | Phospho-tau231 (p-tau231) antigen |
2. Capture antibody | 2. GMP-h-p-tau231-Ab01 | Anti-human p-tau231 mouse monoclonal antibody(mAb) | |
3. Detector antibody | 3. GMP-h-Tau-Ab03 | Recombinant human Tau Protein |
Catalog No. | Products Name | Biomarker | Fc/Tag | Products Information |
GMP-h-p-tau202/205-Ab | Anti-human p-tau202 and 205 monoclonal antibody(mAb) | Phospho-tau202 and 205 (p-tau202 and 205) | hFc/mFc | Details |
GMP-h-p-tau212/214-Ab | Anti-human p-tau212 and 214 monoclonal antibody(mAb) | Phospho-tau212 and 214 (p-tau212 and 214) | hFc/mFc | Details |
GMP-h-p-tau413-Ab | Anti-human p-tau413 monoclonal antibody(mAb) | Phospho-tau413 (p-tau413) | hFc/mFc | Details |
GMP-h-p-tau422-Ab | Anti-human p-tau422 monoclonal antibody(mAb) | Phospho-tau422 (p-tau422) | hFc/mFc | Details |
GMP-h-Tau-Ab | Anti-human Tau monoclonal antibody(mAb) | tau proteins (Tau) | hFc/mFc | Details |
Target/Biomarker information
Alzheimer Disease (AD) Recent publications and meeting presentations bolster the evidence that upticks in p-tau181, p-tau217, and p-tau231 occur soon after Aβ begins to accumulate in the brain. That’s years before neurofibrillary tangles can be detected by PET, and decades before symptoms. Researchers predict these markers, which also distinguish AD from other forms of dementia, will lead to more robust tests than those based on Aβ, because of their larger dynamic range—phosphorylated fragments of tau climb by as much as 10-fold in the blood as AD progresses, whereas the Aβ42/40 ratio falls by about 15 percent at most.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments